ColaLife is not like most other organisations. We are working on a solvable problem and so we are planning for our own demise. All we want to leave behind is a game-changing approach to the home treatment of diarrhoea in developing countries. To do this we need to give away all our learning, findings and our product and process designs so that we can influence the strategies of existing organisations, which already have responsibility for delivering or funding child health. These organisations include:
- National governments and especially Ministries of Health
- National and regional medicine regulators
- International and national NGOs with an interest in child health
- Donors and other funders of child health programmes
- The pharmaceutical industry at international, regional and national levels
If you represent any of the above groups and would like access to our learning and findings please see the ColaLife Playbook. The playbook documents the ColaLife experience and is aimed specifically at those wishing to radically improve access to diarrhoea treatment, specifically co-packaged oral rehydration salts and zinc (ORSZ), in geographies where diarrhoea contributes to high levels of morbidity and mortality. The Playbook is a live document supported by ColaLife where users can ask questions and suggest edits.
ColaLife’s strategy for impact is now in its final phase. In Jan-2022, working with others, we launched the ORS/Zinc Co-pack Alliance to make co-packaged ORS and Zinc the ‘go-to’ treatment for diarrhoea – to advocate the new WHO co-packaging treatment recommendation which we helped to secure in 2019.
We’re extremely grateful to our many supporters who have been with us on this journey.
Last reviewed on 8-May-22
